Your Input: | |||||
IL17A | Interleukin 17A. (155 aa) | ||||
ENSGGOP00000051997 | C-type lectin domain containing 7A. (247 aa) | ||||
ENSGGOP00000050319 | Advanced glycosylation end-product specific receptor. (411 aa) | ||||
ENSGGOP00000049072 | Protein kinase domain-containing protein. (296 aa) | ||||
PLCB1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase; The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. (1216 aa) | ||||
ENSGGOP00000040205 | Galectin. (355 aa) | ||||
CD40LG | CD40 ligand; Cytokine that acts as a ligand to CD40/TNFRSF5. Costimulates T-cell proliferation and cytokine production. Involved in immunoglobulin class switching. (261 aa) | ||||
ENSGGOP00000035952 | TNF receptor-associated factor. (485 aa) | ||||
IRF5 | Interferon regulatory factor 5. (499 aa) | ||||
IDO1 | Indoleamine 2,3-dioxygenase 1. (403 aa) | ||||
PLCG2 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma; Mediates the production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). Plays an important role in the regulation of intracellular signaling cascades. (1265 aa) | ||||
RELA | RELA proto-oncogene, NF-kB subunit. (551 aa) | ||||
TLR3 | Toll-like receptor 3 precursor; Belongs to the Toll-like receptor family. (904 aa) | ||||
SCIMP | SLP adaptor and CSK interacting membrane protein. (144 aa) | ||||
CD40 | CD40 molecule. (277 aa) | ||||
IRF8 | Interferon regulatory factor 8. (426 aa) | ||||
MAPK11 | Mitogen-activated protein kinase. (325 aa) | ||||
MDK | Midkine. (143 aa) | ||||
TIRAP | TIR domain containing adaptor protein. (221 aa) | ||||
TNFSF4 | TNF superfamily member 4; Belongs to the tumor necrosis factor family. (183 aa) | ||||
LAPTM5 | Lysosomal protein transmembrane 5. (262 aa) | ||||
CCR7 | C-C motif chemokine receptor 7; Belongs to the G-protein coupled receptor 1 family. (378 aa) | ||||
IRF1 | Interferon regulatory factor. (325 aa) | ||||
RIPK2 | Receptor-interacting serine/threonine-protein kinase 2; Serine/threonine/tyrosine kinase that plays an essential role in modulation of innate and adaptive immune responses. Upon stimulation by bacterial peptidoglycans, NOD1 and NOD2 are activated, oligomerize and recruit RIPK2 through CARD-CARD domains. (540 aa) | ||||
NOD2 | Nucleotide binding oligomerization domain containing 2. (1040 aa) | ||||
SYK | Tyrosine-protein kinase. (635 aa) | ||||
ISL1 | ISL LIM homeobox 1. (351 aa) | ||||
HSPD1 | Heat shock protein family D (Hsp60) member 1; Belongs to the chaperonin (HSP60) family. (609 aa) | ||||
IL23R | Interleukin 23 receptor. (629 aa) | ||||
CD36 | CD36 molecule; Belongs to the CD36 family. (472 aa) | ||||
IFNG | Interferon gamma; Produced by lymphocytes activated by specific antigens or mitogens. IFN-gamma, in addition to having antiviral activity, has important immunoregulatory functions. It is a potent activator of macrophages, it has antiproliferative effects on transformed cells and it can potentiate the antiviral and antitumor effects of the type I interferons. (166 aa) | ||||
G3QT80_GORGO | Lymphotoxin beta; Belongs to the tumor necrosis factor family. (244 aa) | ||||
TRAF6 | TNF receptor-associated factor; Belongs to the TNF receptor-associated factor family. (522 aa) | ||||
IL16 | Pro-interleukin-16; Interleukin-16 stimulates a migratory response in CD4+ lymphocytes, monocytes, and eosinophils. Primes CD4+ T-cells for IL-2 and IL-15 responsiveness. Also induces T-lymphocyte expression of interleukin 2 receptor. Ligand for CD4. (1331 aa) | ||||
IL12B | Interleukin-12 subunit beta; Cytokine that can act as a growth factor for activated T and NK cells, enhance the lytic activity of NK/lymphokine-activated killer cells, and stimulate the production of IFN-gamma by resting PBMC. (328 aa) | ||||
CCL19 | C-C motif chemokine. (98 aa) | ||||
IL23A | Interleukin 23 subunit alpha. (189 aa) | ||||
LEP | Leptin; Key player in the regulation of energy balance and body weight control. Once released into the circulation, has central and peripheral effects by binding LEPR, found in many tissues, which results in the activation of several major signaling pathways (By similarity). In the hypothalamus, acts as an appetite-regulating factor that induces a decrease in food intake and an increase in energy consumption by inducing anorexinogenic factors and suppressing orexigenic neuropeptides, also regulates bone mass and secretion of hypothalamo-pituitary-adrenal hormones. In the periphery, inc [...] (167 aa) |